MTO-derived tumors exhibited enhanced stromal activation, as indicated by abundant collagen deposition, accompanied by increased THBS1 expression, in contrast to tumors derived from MC38, a widely used mouse colon tumor cell line resembling immunogenic CRC (Supplementary Fig. 2e–g). This evidence concerns the gene SELENBP1 and colorectal carcinoma.